Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention - Concepedia

Concepedia

Publication | Closed Access

Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention

121

Citations

29

References

2013

Year

Sanjeev Pattni, W. G. Brydon, Tracy Dew, Ian Johnston, J D Nolan, M. Srinivas, Pandurangan Basumani, Karna Dev Bardhan, Julian R.F. Walters

Alimentary Pharmacology & Therapeutics

Abstract

Reduced fibroblast growth factor 19 is a feature of bile acid diarrhoea. Further studies will fully define its role in predicting the response of these patients to therapy.

References

	Year	Citations

Page 1